News|Articles|December 9, 2024
Characterization and Release Testing for AAV Therapies
Author(s)Charles River
Characterization and Release Testing for AAV Therapies – the Importance of Empty/Partial/Full Capsid Analysis and its Impact on Potency
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
4
Charles River Incubator Cohort to Accelerate CGT Development
5
